Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer
Clinical trial NCT04993014 · RECRUITING
Trial details
- NCT number
- NCT04993014
- Sponsor
- AC Camargo Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2024-04-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.